BACKGROUND OF THE INVENTION Detection or detection and imaging of molecules and/or biological processes is an area of scientific and medical importance which is in constant need for innovation.

Visual imaging is of particular value to the medical imaging industry and to the pharmaceutical industry. In medical imaging, there is a demand for new imaging agents (contrast agents or diagnostic agents) that enhance the assessment of one or more of healthy tissue, a disease process affecting tissue, and a disease state of affected tissue. As to the pharmaceutical industry, in drug development it is particu- larly important to monitor one or more of: (a) the distribu- tion of the drug in a particular target organ or tissue; (b) the interaction of the drug within the organ or tissue; (c) internalization of the drug by tissue cells, when the target of action is intracellular; and (d) metabolism or bioclear- ance of the drug in living tissues.

Typically, conventional fluorescent labels (e. g., fluorescein, rhodamine, phycoerythrin, an the like) are used for fluorescence detection and/or imaging. These conven- tional fluorescent labels typically have an excitation

spectrum that may be quite narrow; and hence it is often difficult to find a wavelength spectrum of light suitable for simultaneously exciting several different fluorescent labels (e. g., differing in color of fluorescence emission).

However, even when a single light source is used to provide a excitation wavelength spectrum (in view of the spectral line width), often there is insufficient spectral spacing between the emission optima of different species (e. g., dif- fering in color) of fluorescent labels to permit individual and quantitative detection without substantial spectral overlap. Thus, when using a combination of different fluorescent labels, multiple filters are typically needed to detect the resultant emission spectra of the combination.

For example, for fluorescent detection of a substrate label- ed with fluoroscein isothiocyanate (FITC), a filter cube comprising a FITC dichromic filter set is used (excitation at 450-490 nm, and peak emission at 520 nm). This example illustrates the current state of the art of fluorescence filter cubes ("fluorescence cubes"). That is, a fluorescence cube is typically designed to ensure that the substrate is excited by a desired short wavelength (specific for the specie of fluorescent label sought to be detected), and detection of wavelengths in a limited spectral band. Table 1 further illustrates the current state of the art of conventional fluorescence cubes comprised of a dichroic mirror (shown is emission wavelength cutoff; i. e., less than the emission wavelength cutoff is reflected away, greater than emission wavelength cutoff is passed onto the barrier filter), an exciter filter (shown is spectrum of incident light), a barrier filter (shown is wavelength cutoff; i. e., less than wavelength cutoff is blocked, greater than wave- length cutoff is passed onto the detector), and fluorochrome detected by the fluorescence cube.

Table 1

Dichroic Exciter filter Barrier Fluorochrome mirror filter 400 nm 330 nm-385 nm 420 nm DAPI, Hoechst 33342 455 nm 400 nm-410 nm 455 nm Catecholamine, Serotonin 455 nm 400 nm-440 nm 475 nm Quinacrine 455 nm 420 nm-440 nm 475 nm Acriflavine, Thioflavin S 500 nm 450 nm-480 nm 515 nm FITC 500 nm 470 nm-490 nm 515 nm Acridine orange 570 nm 510 nm-550 nm 590 nm Rhodamine, Propidium iodide, TRITC 600 nm 545 nm-580 nm 610 nm Texas red Current techniques for acquiring multicolor fluorescence images, using a filter-based imaging method to measure the fluorescence from a substrate labeled with multiple fluorescent labels, are both time-consuming and complicated. Typically, no more than 3 different fluores- cent labels may be used due to limitations related to dif- ferent excitation spectra and different emission spectra.

Multicolor fluorescence images are then acquired, one image for each fluorescent label used, by rotating a filter wheel into place. The filter wheel has various filters, wherein each filter or a filter combination is used for a specific fluorescent label (See, e. g., Table 1). Additionally, it is often necessary to make adjustments for each peak wavelength spectrum (i. e., for each label used) such as readjusting the focus of the image, and/or selecting an optimal exposure time for each peak emission spectrum when using a detection system that includes a charge coupling device (CCD) camera.

A series of monochrome images are generated, each image corresponding to the peak emission spectrum of a specific fluorescent label. These images are false-colored and then superimposed onto one image using a computer.

Recently, a new class of fluorescent labels have been, and continued to be, developed for use in biological, biomedical, and biochemical applications. These fluorescent labels comprise water-soluble semiconductor nanocrystals ("quantum dots")."Water-soluble"is used herein to mean sufficiently soluble or suspendable in a aqueous-based solution, such as in water or water-based solutions or physiological solutions, including those used in the various fluorescence detection systems as known by those skilled in the art. Generally, quantum dots can be prepared which result in relative monodispersity; e. g., the diameter of the core varying approximately less than 10% between quantum dots in the preparation. Examples of quantum dots are known in the art to have a core selected from the group consisting of CdSe, CdS, and CdTe (collectively referred to as"CdX").

CdX quantum dots have been passivated with an inorganic coating ("shell") uniformly deposited thereon. Passivating the surface of the core quantum dot can result in an increase in the quantum yield of the fluorescence emission, depending on the nature of the inorganic coating. The shell which is used to passivate the quantum dot is preferably comprised of YZ wherein Y is Cd or Zn, and Z is S, or Se.

Typically, CdX core/YZ shell quantum dots are overcoated with trialkylphosphine oxide, with the alkyl groups most commonly used being butyl and octyl. One method to make the CdX core/YZ shell quantum dots water-soluble is to exchange this overcoating layer with a coating which will make the

quantum dots water-soluble. For example, a mercaptocarboxyl- ic acid may be used to exchange with the trialkylphosphine oxide coat. Exchange of the coating group is accomplished by treating the water-insoluble quantum dots with a large excess of neat mercaptocarboxylic acid. Alternatively, exchange of the coating group is accomplished by treating the water-insoluble quantum dots with a large excess of mercaptocarboxylic acid in CHC13 solution. The thiol group of the new coating molecule forms Cd (or Zn)-S bonds, creating a coating which is not easily displaced in solution. Generally, these"water-soluble"quantum dots require further functionalization to make them sufficiently stable in an aqueous solution for practical use in a fluorescence detection system (as described in more detail in U. S. Pat. No. 6,114,038), particularly when exposed to air (oxygen) and/or light. Water-soluble functionalized nanocrystals are extremely sensitive in terms of detection, because of their fluorescent properties (e. g., including, but not limited to, high quantum efficiency, resistance to photobleaching, and stability in complex aqueous environ- ments); and comprise a class of semiconductor or doped rare earth nanocrystals that may be excited with a single peak wavelength of light resulting in detectable fluorescence emissions of high quantum yield and with discrete fluores- cence peaks (e. g., having a narrow spectral band ranging between about 10 nm to about 60 nm).

However, there lacks an optical system comprising a single fluorescence cube which could be used for detect- ing, or detecting and imaging, (collectively referred to hereinafter as"acquiring") fluorescence spectra generated by a combination of different fluorescent labels used

together in multicolor fluorescence analysis of a labeled substrate. More particularly, there is a need for a simple device that enables the simultaneous measurement of the emission spectrum of each of a plurality of different species (e. g., differing in emission spectrum, and hence color) of water-soluble semiconductor nanocrystals which are used in a combination to achieve multicolor fluorescence analysis.

SUMMARY OF THE INVENTION The present invention provides a detection system for acquiring fluorescence spectra generated by a combina- tion of different water-soluble semiconductor nanocrystals used together in multicolor fluorescence analysis of a labeled substrate. The detection system is capable of simultaneously acquiring fluorescence spectra from all pixels of a field of view, such as provided by a fluores- cence microscope or other optical imaging device; and hence, can simultaneously detect in a single measurement the locations in a substrate of one or more labeled affinity ligands. Each type of affinity ligand may be labeled with one or more of a different water-soluble semiconductor nano- crystal (e. g., differing in discrete emission spectrum) than that used to label the other types of affinity ligand. Using a single fluorescence cube according to the present inven- tion to acquire a wide range of fluorescence spectra has been found to save time, effort, and expense, that is otherwise spent on choosing optimal filters for a filter- based measurement of each emission spectrum. By enabling the simultaneous measurement of the emission spectra from a number of different water-soluble semiconductor nanocrys-

tals, eliminated is the need for false color imaging, and the need to sequentially acquire images one emission spectrum at a time.

In one embodiment, the detection system is a reflected illumination system comprising a fluorescence cube. The fluorescence cube comprises a housing; and an exciter filter and a dichroic mirror which are operatively positioned in, and secured to, the housing. The cube may further comprise a barrier filter. However, in the detec- tion system according to the present invention, and in addition to a housing, the cube comprises an exciter filter and dichroic mirror combination selected such that, unlike prior art cubes, multicolor fluorescence images can be acquired using a single cube, as obtained by labeling with different species of water-soluble semiconductor nanocrys- tals. The fluorescence cube may be used to detect any water-soluble fluorescent nanocrystals for any application in which acquiring one or more fluorescence emission spec- trum is desired. However, a preferred application may be practiced to the exclusion of applications other than the preferred application.

In another embodiment, the detection system is a reflected illumination system comprising a fluorescence cube. The fluorescence cube comprises a housing, an exciter filter, a regular beam splitter, and a barrier filter. In this detection system according to the present invention, the combination comprising the exciter filter, the beam splitter, and the barrier filter is selected such that, unlike prior art cubes, multicolor fluorescence images can be acquired using a single cube, as obtained by labeling with different species of water-soluble semiconductor nano-

crystals. The fluorescence cube may be used to detect any water-soluble fluorescent nanocrystals for any application in which acquiring an emission spectral range comprising one or more fluorescent emission spectrum is desired. However, a preferred application may be practiced to the exclusion of applications other than the preferred application.

The above and other objects, features, and advantages of the present invention will be apparent in the following Detailed Description of the Invention when read in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a graph illustrating the spectral range of emission wavelengths capable of being detected with one embodiment of the fluorescence cube according to the present invention.

FIG. 2 is a black and white photographic representation showing liver endothelium labeled with water-soluble nanocrystals, as imaged in color using a fluorescence cube according to the present invention.

FIG. 3 is a black and white photographic representation of showing cells labeled in a multicolor analysis and imaged in color using a fluorescence cube according to the present invention, wherein: FIG. 3A is a representative image of all colors from the labeled cells; FIG. 3B is a representative image of red color from the labeled cells; FIG. 3C is a representative image of green color from the labeled cells; and

FIG. 3D is a representative image of blue color from the labeled cells.

DETAILED DESCRIPTION OF THE INVENTION Definitions By the term"substrate"is meant, for the purposes of the specification to refer to a molecule of an organic nature (e. g., microorganism (bacterial, viral, etc.), tissue component, etc.) or inorganic nature (e. g., chemical), the presence and/or quantity of which is being tested for; and which contains a molecular component (domain or sequence or receptor or epitope or portion or chemical group or deter- minant) for which the affinity ligand has binding specifi- city. The nature of the substrate is not critical to the invention, as a wide variety of substrates are the subject of fluorescence analyses as known to those skilled in the art. It may be a molecule that includes, but is not limited to, a nucleic acid molecule, protein, glycoprotein, eukaryo- tic or prokaryotic cell, lipoprotein, peptide, carbohydrate, lipid, phospholipid, aminoglycans, chemical messenger, bio- logical receptor, structural component, metabolic product, enzyme, antigen, drug, therapeutic, toxin, inorganic chemical, organic chemical, and the like. The substrate may be extracellular, intracellular, in vivo, in vitro, in situ, or ex vivo.

By the term"affinity ligand"is meant, for purposes of the specification, to mean a molecule which has binding specificity and avidity for a molecular component of, or associated with, a substrate. The nature of the affinity ligand is not critical to the invention, as a wide variety of affinity ligands are used as targeting molecules in

fluorescence analyses as known to those skilled in the art.

In general, affinity ligands are known to those skilled in the art to include, but are not limited to, lectins or frag- ments (or derivatives) thereof which retain binding func- tion; monoclonal antibodies ("mAb", including chimeric or genetically modified monoclonal antibodies (e. g.,"human- ized"), and immunoreactive fragments of mAb as known to those skilled in the art); peptides; aptamers; nucleic acid molecules (including, but not limited to, single stranded RNA or single-stranded DNA, or single-stranded nucleic acid hybrids); avidin, or streptavidin, or avidin derivatives; a drug; and the like. The invention may be practiced using a preferred affinity ligand to the exclusion of affinity ligands other than the preferred affinity ligand.

By the term"fluorescence analysis"is meant, for pur- poses of the specification and claims, to mean any method known to those skilled in the art by which a substrate is fluorescently labeled, and acquired is any fluorescence emission of an excited, labeled substrate. Fluorescence labeling is achieved by using water-soluble nanocrystals having one or more affinity ligands operably linked thereto, as previously described herein. Exemplary methods may include, but are not limited to, a fluorescence-based immunoassay, fluorescence microscopy, fluorescence endoscopy (see, e. g., U. S. Patent No. 5,891,016), flow cytometry, fluorescence in-situ hybridization, nucleic acid amplifica- tion with one or more fluorescently labeled nucleotides, nucleic acid sequencing using one or more fluorescently labeled nucleotides, fluorescence imaging, and the like. The invention may be practiced using a preferred fluorescence analysis to the exclusion of fluorescence analyses other

than the preferred fluorescence analysis. Likewise, the fluorescence cube according to the present invention may be operatively coupled to an instrument used in acquiring fluorescence spectra for fluorescence analysis. As an illustrative, non-limiting example, the fluorescence cube may operatively coupled to an appropriate detection means or system which may include, but is not limited to, one or more of: one or more photodetectors, a filter, a CCD camera, a fluorescence microscope, an endoscopic imaging system, an endoscopic fluorescence imaging microscope, a fiber optic fluorescence imaging microscope, a computer used in the fluorescence analysis, and the like.

By the term"spectral range"is meant, for purposes of the specification and claims, to mean a wavelength range comprising a"low wavelength value"wherein light of less than the low wavelength value is blocked or reflected or otherwise excluded; and a"high wavelength value"wherein light of greater than this high wavelength value is blocked or reflected or otherwise excluded, as will be more apparent from the following descriptions.

Generally, each species of water-soluble fluores- cent nanocrystals can be excited, by exposure to an appro- priate excitation spectrum, to emit an emission spectrum and fluorescence peak in the spectral range of about 400 nm to about 750 nm. As known to those skilled in the art of nanocrystals, the absorbance peak and fluorescence peak emission depend on properties of the nanocrystals which may include, but are not limited to, the chemical nature, doping agent (if any), and core size. The following are illustra- tive examples of altering the size of the nanocrystal to

achieve various colors. Water-soluble CdSe/ZnS nanocrystals having a substantially uniform size comprising a diameter of about 68.4 angstroms (A) may be excited with light in the spectral range of from about 300 nm to about 400 nm, and emit a fluorescence peak (orange) at 609 nm which may be detected using appropriate detection means. Water-soluble CdSe/ZnS nanocrystals having a substantially uniform size comprising a diameter of about 53.2 A may be excited with light of a spectral range of from about 300 nm to about 400 nm, and emit a fluorescence peak (yellow) at 545 nm which may be detected using appropriate detection means. Water- soluble CdSe/ZnS nanocrystals having a substantially uniform size comprising a diameter of about 46.6 A may be excited with light of a spectral range of from about 300 nm to about 400 nm, and emit a fluorescence peak (green) at 522 nm which may be detected using appropriate detection means. Water- soluble CdSe/ZnS nanocrystals having a substantially uniform size comprising a diameter of about 23 A may be excited with light of a spectral range of from about 300 nm to about 400 nm, and emit a fluorescence peak (blue) at 480 nm which may be detected using appropriate detection means.

The fluorescence cube of the present invention was designed for acquiring fluorescence emission (s) associ- ated with use of water-soluble nanocrystals to ensure that the nanocrystals are excited by an excitation light source of a desired wavelength spectral range, and that fluores- cence emission comprising a wavelength spectral range for each representative color used in the analysis can be trans- mitted to an appropriate detector means. In one embodiment, the fluorescence cube comprises a housing, an exciter fil- ter, and a dichroic mirror. A light source is illuminated

through an opening in the housing to the excitor filter, wherein the exciter filter allows only light of certain wavelength (s) to pass through ("incident light"). In a preferred embodiment, the incident light from the exciter filter comprises a spectral range of from about 200 nm to about 400 nm; and in a more preferred embodiment, the incident light from the exciter filter comprises a spectral range of from about 310 nm to about 400 nm with a maximum transmission peak of from about 360 nm to about 365 nm; and in another preferred embodiment, the incident light from the exciter filter comprises a spectral range of from about 355 nm to about 375 nm with a maximum transmission peak at about 365 nm.

In continuing with this illustrative example, the incident light from the exciter filter reaches the dichroic mirror. In a preferred arrangement, the dichroic mirror is operatively positioned at an angle of 45° with respect to the optical axis of the incident light from the exciter filter, thereby reflecting the light comprising the excitation spec- tral range in a desired direction; e. g., through an opening in the housing, towards an objective, and to a sample comprising the substrate. If the substrate is labeled with the water-soluble nanocrystals used in the fluorescence analysis, exposing the nanocrystals to an excitation light will cause the nanocrystals to become excited and emit an emission spectral range that is dependent on the species of water-soluble nanocrystals used to label the substrate. For example, where a plurality of species (e. g., differing in size) of water soluble nanocrystals is used to perform multicolor fluorescence analysis, the emitted light will comprise emitted fluorescence spectra of a plurality of

discrete fluorescence peaks in a spectral range of about 420 nm to about 800 nm, dependent upon the species of functionalized nanocrystals used. Thus, light emitted from the sample then reaches the dichroic mirror; e. g., is passed back up through the objective and an opening in the housing to the dichroic mirror. The dichroic mirror may be chosen to reflect in a direction away from the detector means substantially all unwanted wavelengths of light emitted from the sample, and transmits (e. g., reflects) emitted light comprising a selected spectral range in a desired direction; e. g., directs passage of the emitted light of a selected spectral range through an opening in the housing and to the detector means. In one preferred embodiment, and as shown in FIG. 1, the dichroic mirror transmits to the detector means an emitted light in the spectral range comprising from about 415 nm to about 800 nm. Thus, in this preferred embodiment, reflected away is any emitted light comprising wavelengths less than about 415 nm and light comprising wavelengths greater than about 800 nm; and transmitted to the detector means is emitted light of a spectral range between about 415 nm and about 800 nm. In another preferred embodiment, the dichroic mirror transmits to the detector means an emitted light in the spectral range comprising from about 415 nm to about 750 nm. In both of these preferred embodiments, the dichroic mirror is chosen so as to enable transmission of emitted fluorescence in a spectral range that corresponds to colors ranging from blue to green to yellow to orange to red, as found in the visible spectrum.

The emission spectral range that is transmitted may also correspond to variations of these primary colors (e. g., a green-yellow).

The fluorescence cube may further comprise a barrier filter, operatively positioned between the dichroic mirror and the detector means, to ensure that blocked out from reaching the detector means is any light that may be undesirable or harmful (e. g., wavelengths of light of a spectral range of less than 400). For example, where the detector means comprises an eyepiece of a fluorescence microscope, wavelengths of less than 400 nm that reach the eyepiece may be harmful to the eyes of the viewer. Accord- ingly, in instances in which the dichroic mirror does not function to reflect away from the detector means all of such unwanted wavelengths of light emitted from the sample, the barrier filter may function to block out such unwanted wave- lengths before the transmitted light reaches the detector means. Thus, the fluorescence cube according to the present invention may further comprise a barrier filter, operatively positioned between the dichroic mirror and detector means, which may eliminate undesirable light from reaching the detector means. The undesirable light emitted from the sample may comprise background fluorescence. Sources of background fluorescence include, but are not limited to, auto-fluorescence of the sample comprising the substrate, and unwanted fluorescence resulting from selection of an inappropriate or sub-optimal (e. g., quality or property or positioning of) dichroic mirror and/or exciter filter. In a preferred embodiment of the present invention, the barrier filter blocks out light of less than about 400 nm from reaching the detector means; and in another preferred embodiment, the barrier filter blocks out light of less than about 420 nm from reaching the detector means.

In another embodiment, the fluorescence cube comprises a housing, an exciter filter and a dichroic mirror. Preferably, the incident light from the exciter filter comprises a spectral range of from about 200 nm to about 400 nm. Also preferable, the incident light from the exciter filter comprises a spectral range of from about 310 nm to about 400 nm with a maximum transmission peak of from about 360 nm to about 365 nm. Also preferably, the incident light from the exciter filter comprises a spectral range of from about 355 nm to about 375 nm with a maximum transmis- sion peak at about 365 nm. In a preferred arrangement, the dichroic mirror is operatively positioned at an angle of 45° with respect to the optical axis of the incident light, thereby reflecting the incident light comprising the excita- tion spectral range in a desired direction; e. g., through an opening in the housing and towards an objective and through to a sample comprising the substrate. The excitation light will then cause the nanocrystals, when present with the substrate, to become excited and emit an emission spectral range that is dependent on the species of water-soluble nanocrystals used to label the substrate. The dichroic mirror may be chosen to reflect in a direction away from the detector means substantially all unwanted wavelengths of light emitted from the sample, and transmit to the detector means an emitted light comprising a selected emission spectral range. In this illustrative embodiment, the dichroic mirror is selected and operatively positioned to transmit emitted light to the detector means comprising only a portion of the spectral range of from about 415 nm to about 800 nm. For example, the dichroic mirror may be chosen to transmit emitted light in the spectral range of

from about 415 nm to about 550 nm, which would correspond to detection of colors ranging from blue to green to yellow in a multicolor fluorescence analysis. In another example, the dichroic mirror may be chosen to transmit emitted light in the spectral range of from about 530 nm to about 750 nm, which would correspond to detection of colors ranging from yellow to orange to red in a multicolor fluorescence analy- sis. The dichroic mirror may be chosen to transmit other spectral ranges of emitted light comprising a portion of the range of from about 415 nm to about 800 nm, as will be apparent to those skilled in the art based on the descrip- tions herein. The invention may be practiced using a dichroic mirror that transmits a preferred spectral range comprising a portion (ranging over a spectral band of about 100 nm or greater) of the range of from about 415 nm to about 800 nm to the exclusion of spectral ranges other than the preferred spectral range. The fluorescence cube accord- ing to this embodiment may further comprise a barrier filter operatively positioned between the dichroic mirror and the detector means. Preferably, the barrier filter blocks out light of less than about 400 nm from reaching the detector means; and also preferred, the barrier filter blocks out light of less than about 420 nm from reaching the detector means.

In another embodiment, the fluorescence cube comprises a housing, an exciter filter and a beam splitter.

Preferably, the incident light from the exciter filter comprises an excitation spectral range of from about 200 nm to about 400 nm. Also preferable, the incident light from the exciter filter comprises a spectral range of from about 310 nm to about 400 nm with a maximum transmission peak at

about 360 nm to about 365 nm. Also preferably, the incident light from the exciter filter comprises a spectral range of from about 355 nm to about 375 nm with a maximum trans- mission peak at about 365 nm. The beam splitter is chosen and operatively positioned to direct various beams of light provided thereto to different paths. Thus, any type of beam splitter including a prism type, a plate type, and the like may be used as long as they function as beam splitters.

Thus, one function of the beam splitter is to direct a proportion of the incident light comprising an excitation spectral range in a desired direction; e. g., through an opening in the housing and towards an objective and through to a sample comprising the substrate. The excitation light will then cause the nanocrystals, when present with the substrate, to become excited and emit a spectral range that is dependent on the species and number of species of water- soluble nanocrystals used to label the substrate. Thus, another function of the beam splitter is to then direct light emitted from the sample (e. g., emitted light); i. e., may reflect away from the detector means substantially all unwanted wavelengths of light, and direct emitted light comprising a selected emission spectral range in a desired direction (e. g., through an opening in the housing to the detector means). In a preferred embodiment, the beam splitter directs away from the detector means all light emitted from the sample which is less than about 400 nm; and more preferably, directs away from the detector means all light emitted from the sample which is less than about 420 nm. Thus, the beam splitter is chosen, constructed, and operatively positioned to have a spectral range selection function wherein transmitted through to the detector means

is a selected spectral range (e. g., a spectral range of light greater than about 400 nm, or a spectral range of light greater than about 420 nm) which includes the emission spectral range; and directed away from the detector means is emitted light of a selected spectral range (e. g., a spec- tral range of light less than about 400 nm, or a spectral range of light less than about 415 nm). In addition to directing away from the detector means light of less than a certain wavelength (e. g., about 400 nm, or about 415 nm, or about 420 nm), the beam splitter may further act to direct away light merging from the sample which is greater than a certain wavelength (e. g., about 750 nm, or about 800 nm).

In one variation of an embodiment using a beam splitter, the emitted light which is transmitted by the beam splitter to the detector means comprises a single beam. In another variation of this embodiment, and in particular wherein the beam splitter comprise a prism type beam split- ter and wherein the detector means comprises a combination of R, G, and B coded photodetectors, the emitted light transmitted by the beam splitter to the detector means comprises a plurality of beams. For example, a beam of a selected spectral range may be transmitted by the beam splitter to the R coded photodetector, a beam of a selected spectral range may be transmitted to the G coded photo- detector, and a beam of a selected spectral range may be transmitted to the B coded photodetector. Each of the plurality of beams may comprise a spectral range that may be the same or may differ (as compared to the spectral range of one or more of the other beams of the plurality), as may be appropriate for the photodetector to which it is transmit- ted. In another variation of this embodiment, the beam

splitter is selected and operatively positioned to transmit emitted light to the detector means comprising only a portion of the spectral range of from about 415 nm to about 800 nm. For example, the beam splitter may be chosen to transmit emitted light in the spectral range of from about 415 nm to about 550 nm, which would correspond to detection of colors ranging from blue to green to yellow in a multi- color fluorescence analysis. In another example, the beam splitter may be chosen to transmit emitted light in the spectral range of from about 530 nm to about 750 nm, which would correspond to detection of colors ranging from yellow to orange to red in a multicolor fluorescence analysis. The beam splitter may be chosen to transmit other spectral ranges comprising a portion of the range of from about 415 nm to about 800 nm, as will be apparent to those skilled in the art based on the descriptions herein. The invention may be practiced using a beam splitter that transmits a prefer- red spectral range comprising a portion (ranging over a spectral band of about 100 nm or greater) of the range of from about 415 nm to about 800 nm to the exclusion of spectral ranges other than the preferred spectral range.

The fluorescence cube according to this embodiment may further comprise a barrier filter operatively positioned between the beam splitter and the detector means. Prefer- ably, the barrier filter blocks out light of less than about 400 nm from reaching the detector means; and also preferred, the barrier filter blocks out light of less than about 420 nm from reaching the detector means.

EXAMPLE 1 This example illustrates fluorescent analysis in which the fluorescence cube is used in a detection system.

In this illustration, produced were water-soluble nano- crystals comprising a core, a shell, a capping compound comprising the formula HS (CH2) nX wherein X is a carboxylate, a diaminocarboxylic acid which is operably linked to the capping compound, and an affinity ligand (comprising lectin wheat germ agglutinin,"WGA") which is operably linked to the diaminocarboxylic acid (WGA at a concentration approxi- mated to be about one nanocrystal per lectin molecule). The functionalized nanocrystals were of a monodisperse size for emitting a yellow fluorescence in imaging a substrate. The functionalized nanocrystals were used to image liver tissue morphology; and in particular, sinusoidal liver endothelium and its distribution in the liver. The target substrates in the sinusoidal liver endothelium are sinusoidal liver endothelial cells, termed LEC-1 cells, which preferentially express N-acetyl glucosamine in higher concentrations than most other liver endothelial cell populations, and which are adjacent to portal veins ("periportal"). WGA, having bind- ing specificity for N-acetyl glucosamine, was used as the affinity ligand of the functionalized nanocrystals to target the substrate, LEC-1 expressing N-acetyl glucosamine, in the living tissue to be imaged.

In continuing with this illustration, a BALB/c mouse was anesthetized and then placed in a supine position.

Heparin (0.1 ml) was administered, and after a ten minute delay, the abdomen was surgically opened. The portal vein was exposed by upward traction on the underside of the liver and downward counter action on the duodenum, and inserted

therein was a plastic tube connected to a syringe. Via the syringe, phosphate buffered saline (PBS) was perfused through the liver at a rate of about 0.1 ml per second, for a total of 5-10 ml of perfusion. The PBS and displaced blood was allowed to exit through a severed vein. An effec- tive amount of the functionalized nanocrystals was diluted in 1 ml of PBS, in a final concentration of 8. 1 x 10-7 M (WGA concentration approximated to be about 29 pg/ml) and the mixture was then perfused at 0.1 ml/second. The mixture was allowed to remain in the liver for about 5 to 10 minutes, and then the liver was perfused again with between 5 to 10 ml of PBS. This perfusion was intended to remove any unbound or non-specifically functionalized nanocrystals from the liver. The liver was removed, and then processed. In this illustration, processing of the tissue comprised freezing the liver in a cryostat (-20°C), and cutting of frozen sections (5-10 p). Frozen sections were placed on slides within the cryostat, and air-dried at room tempera- ture; some slides were fixed with alcohol; and all slides were treated with mounting fluid and cover-slipped. Various mounting fluids were used; e. g., gel mount, crystal mount, or cytoseal, for microscopy. A few of the sections, before cover-slipping, were also processed by counter-staining with DAPPI for visualization of the nuclei of hepatocytes and endothelial cells (e. g., to give a background which enhanced the contrast and details, such as positioning, of the fluorescing cells of the tissue relative to other cells in the liver).

The sections were imaged by a detection system comprising a fluorescence microscope operatively coupled to a fluorescence cube according to the present invention. In

addition to a housing, the fluorescence cube was comprised of an exciter filter, and a dichroic mirror designed so that transmitted to the detector means (eyepiece, or attached CCD camera) was emitted light of a spectral range of from about 530 nm to about 700 nm. Using this detection system compris- ing the fluorescence cube and the fluorescence microscope, a true color image of liver endothelium, and particularly of the distribution of LEC-1 cells labeled with the functional- ized nanocrystals, was obtained (FIG. 2, black and white image shown). As can be seen in FIG. 2, the acquired fluorescence spectral range is used to image the LEC-1 cells that surround the portal domain sinusoids of the imaged liver. No staining occurs outside of this region. This result is consistent with the known lectin-binding patterns of the liver sinusoids. The detection system may further comprise available computer hardware or software or digital camera (CCD camera) for processing and printing a true color image of the tissue.

EXAMPLE 2 In an illustration of using the fluorescence cube according to the present invention to acquire fluorescence spectra in multicolor fluorescence analysis, two different species of water-soluble nanocrystals were produced. One species of water-soluble nanocrystals was of a monodisperse size for emitting a yellow-green fluorescence, and contained WGA as affinity ligand which is operably linked to diamino- carboxylic acid (WGA at a concentration approximated to be about one nanocrystal per lectin molecule). Another species of water-soluble nanocrystals was of a monodisperse size for emitting a red fluorescence, and contained Peanut agglutinin

(PNA) as the affinity ligand which is operably linked to the diaminocarboxylic acid (PNA at a concentration approximated to be about one nanocrystal per lectin molecule). The two species of functionalized nanocrystals were used to image a combination of two cell types. The murine cells subjected to labeling and imaging comprised LEC-1 cells (expressing N- acetyl glucosamine, and minimal galactosyl (pl, 3) N-acetyl galactosamine), and B16F10 melanoma cells (which express galactosyl (pl, 3) N-acetyl galactosamine and minimal N- acetyl glucosamine). Briefly, 1 million of each cell type was mixed together with 2 ml of buffer (PBS) in forming the cell mixture. The cell mixture was then incubated with effective amounts of the two species of functionalized nanocrystals for 20 minutes at room temperature with gentle agitation. The cell mixture was then centrifuged; the cells were washed three times with buffer to remove unbound and non-specifically bound detector molecules; and then the resultant labeled cells were resuspended in 400 1 of buffer. A sample of 20 p1 of the labeled cells was dropped onto a glass slide; and the slide was coverslipped, and sealed with wax. The coverslipped sample was imaged by a detection system comprising a fluorescence microscope operatively coupled to a fluorescence cube according to the present invention. In addition to a housing, the fluores- cence cube was comprised of an exciter filter, and a dichroic mirror designed so that transmitted to the detector means (eyepiece, or attached CCD camera) was emitted light of a spectral range of from about 415 nm to about 800 nm.

Using this detection system comprising the fluorescence cube operatively coupled to a fluorescence microscope, a true color image of the labeled cells was obtained. More

particularly, the resultant image is shown in FIG. 3. FIG.

3A is a black and white representation of the fluorescing cells (comprising an image in both colors) imaged using the detection system. FIG. 3B is a black and white representa- tion of only labeled cells fluorescing red, as selectively imaged from FIG. 3A using software and a computer to selectively view a certain color. The cells prominently stained red were confirmed by morphology to be B16F10 melanoma cells. FIG. 3C is a black and white representation of only labeled cells fluorescing yellow-green ("green" ; FIG. 3C), as selectively imaged from FIG. 3A. The cells prominently stained green were confirmed by morphology to be LEC-1 cells. FIG. 3D is a black and white representation, as selectively imaged from FIG. 3A, showing that none of the labeled cells are fluorescing blue.

The foregoing description of the specific embodiments of the present invention have been described in detail for purposes of illustration. In view of the descriptions and illustrations, others skilled in the art can, by applying, current knowledge, readily modify and/or adapt the present invention for various applications without departing from the basic concept, and therefore such modifications and/or adaptations are intended to be within the meaning and scope of the appended claims.

What is claimed: